# CARDIFF ONCOLOGY INC (CRDF)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CRDF/

- Reporting holders: 5
- Reported value: $894.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GoalVest Advisory LLC](https://holderbook.com/funds/1839307-goalvest-advisory-llc/) | $831.6K | 687,285 | 0.1% | 1 |
| [Post Resch Tallon Group Inc.](https://holderbook.com/funds/2054476-post-resch-tallon-group-inc/) | $27.2K | 22,515 | 0.0% | 5 |
| [Capital Advisors Wealth Management, LLC](https://holderbook.com/funds/1824700-capital-advisors-wealth-management-llc/) | $18.8K | 15,525 | 0.0% | 4 |
| [Ledgewood Wealth Advisors, LLC](https://holderbook.com/funds/2064043-ledgewood-wealth-advisors-llc/) | $13.5K | 11,190 | 0.0% | 7 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $3.3K | 2,696 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $894.4K |
| Q2 2026 | 108 | $26.1M |
| Q1 2026 | 116 | $41.1M |
| Q4 2025 | 110 | $78.9M |
| Q3 2025 | 113 | $55.5M |
| Q2 2025 | 119 | $95.7M |
| Q1 2025 | 120 | $105.6M |
| Q4 2024 | 117 | $127.9M |
| Q3 2024 | 83 | $36.7M |
| Q2 2024 | 90 | $31.3M |
| Q1 2024 | 77 | $51.9M |
| Q4 2023 | 55 | $8.0M |